Financial reports
No filings
Current reports
No filings
Registration and prospectus
Proxies
No filings
Other
No filings
Ownership
SC 13G/A
Lyell Immunopharma, Inc.
14 Feb 25
SC 13G
Maze Therapeutics, Inc.
7 Feb 25
SC 13G
Maze Therapeutics, Inc.
7 Feb 25
SC 13G
Lyell Immunopharma, Inc.
31 Oct 24
4
Kinnate Biopharma Inc.
5 Apr 24
SC 13G/A
Aclaris Therapeutics, Inc.
13 Feb 24
SC 13G/A
Pharvaris N.V.
13 Feb 24
4
Kinnate Biopharma Inc.
10 May 23
SC 13D/A
Kinnate Biopharma Inc.
10 May 23
SC 13D/A
Kinnate Biopharma Inc.
22 Feb 23